Planning for the Next Pandemic: Ethics and Innovation Today for Improved Clinical Trials Tomorrow-Reference-Cited by-同舟云学术

Planning for the Next Pandemic: Ethics and Innovation Today for Improved Clinical Trials Tomorrow

Published:2021-06-01 Issue:1 Volume:14 Page:22-27
ISSN:1946-6315
Container-title:Statistics in Biopharmaceutical Research
language:en
Short-container-title:Statistics in Biopharmaceutical Research

Author:

McMillan Gianna¹,Mayer Cristiana²,Tang Rui³,Liu Yi⁴,LaVange Lisa⁵,Antonijevic Zoran⁶,Beckman Robert A.⁷

Affiliation:

1. Bioethics Institute, Loyola Marymount University, Los Angeles, CA

2. Johnson & Johnson, MBDD, Titusville, NJ

3. Servier Pharmaceuticals, Boston, MA

4. Nektar Therapeutics, Data Science and Systems, San Francisco, CA

5. Department of Biostatistics, University of North Carolina, Chapel Hill, NC

6. MedSource, Biometrics, Raleigh, NC

7. Departments of Oncology and of Biostatistics, Bioinformatics, and Biomathematics, Lombardi Comprehensive Cancer Center and Innovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington, DC

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Statistics and Probability

Link

https://www.tandfonline.com/doi/pdf/10.1080/19466315.2021.1918236

Reference35 articles.

1. Optimizing the Trade-off Between Learning and Doing in a Pandemic

2. Platform Trial Designs in Drug Development

3. Impact of Platform Trials on Pharmaceutical Frameworks

4. Optimal Approach for Addressing Multiple Stakeholders’ Requirements in Drug Development

5. Decision Analysis from the Perspectives of Single and Multiple Stakeholders

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A primer of quasi-exact tests for randomized clinical trials with binary endpoints;Statistics in Biopharmaceutical Research;2024-09-10

2. Aiding the Adoption of Master Protocols by Optimizing Patient Engagement;Therapeutic Innovation & Regulatory Science;2023-08-24

3. A rapid review of community engagement and informed consent processes for adaptive platform trials and alternative design trials for public health emergencies;Wellcome Open Research;2023-05-02

4. Vaccine Innovation Meta-Model for Pandemic Contexts;Journal of Pharmaceutical Innovation;2023-02-13

5. Statistical Issues and Challenges in Clinical Trials for COVID-19 Treatments, Vaccines, Medical Devices and Diagnostics;Statistics in Biopharmaceutical Research;2021-12-13